IGF2BP1 and osteosarcoma: Osteosarcoma patients with miR-150-low expression or IGF2BP1-high expression more frequently had high tumor grade (both P = 0.02), positive metastasis (both P = 0.001) and recurrence (both P = 0.001), and poor response to chemotherapy (both P = 0.01).